ANTIEPILEPTIC POTENTIAL OF FPL 15896AR

被引：0
|
作者：
WATKINS, BE [1 ]
MURRAY, RJ [1 ]
BALESTRA, M [1 ]
PALMER, GC [1 ]
机构：
[1] FISONS PHARMACEUT,ROCHESTER,NY 14603
来源：
FASEB JOURNAL | 1995年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A394 / A394
页数：1
相关论文
共 50 条
  • [1] ARR 15896 AR. ARL 15896, ARL 15896AR, ARR 15896, FPL 15896, FPL 15896AR.
    不详
    Drugs in R & D, 1999, 1 (1) : 14 - 15
  • [2] Low-affinity NMDA receptor antagonists - The neuroprotective potential of ARL 15896AR
    Palmer, GC
    Miller, JA
    Cregan, EF
    Gendron, P
    Peeling, J
    NEUROPROTECTIVE AGENTS - THIRD INTERNATIONAL CONFERENCE, 1997, 825 : 220 - 231
  • [3] EFFECTS OF ANTICONVULSANTS IN A NOVEL OPERANT LEARNING-PARADIGM IN RATS - COMPARISON OF REMACEMIDE HYDROCHLORIDE AND FPL 15896AR TO OTHER ANTICONVULSANT AGENTS
    HUDZIK, TJ
    PALMER, GC
    EPILEPSY RESEARCH, 1995, 21 (03) : 183 - 193
  • [4] [S]-AR-R 15896AR - A novel anticonvulsant: Acute safety, pharmacokinetic and pharmacodynamic properties
    Palmer, GC
    Murray, RJ
    Cramer, CL
    Stagnitto, ML
    Knowles, MK
    Freedman, LR
    Eismann, MS
    Mahmood, N
    Balestra, M
    Borrelli, AR
    Hudzik, TJ
    McCarthy, DJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 288 (01): : 121 - 132
  • [5] NEUROPROTECTIVE PROFILE OF FPL-15896AR, A NOVEL UNCOMPETITIVE NMDA ANTAGONIST
    MURRAY, RJ
    PALMER, GC
    BALESTRA, M
    CREGAN, EF
    GRIFFITH, RC
    HOWELL, AS
    SLOANE, D
    GREENAMYRE, T
    BUCHAN, AM
    XUE, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 74 - MEDI
  • [6] Remacemide hydrochloride and ARL 15896AR lack abuse potential: Additional differences from other uncompetitive NMDA antagonists
    Hudzik, TJ
    Freedman, L
    Palmer, GC
    EPILEPSIA, 1996, 37 (06) : 544 - 550
  • [7] Antagonism of N-methyl-D-aspartate-evoked currents in rat cortical cultures by ARL 15896AR
    Mealing, GAR
    Lanthorn, TH
    Small, DL
    Black, MA
    Laferriere, NB
    Morley, P
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 281 (01): : 376 - 383
  • [8] The low affinity NMDA receptor antagonist ARR 15896AR reduced hemineglect and infarct size in a primate model of stroke
    Marshall, JWB
    Jones, EJ
    Duffin, KJ
    Green, AR
    Ridley, RM
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 : U88 - U88
  • [9] The low-affinity, use-dependent NMDA receptor antagonist AR-R 15896AR - An update of progress in stroke
    Palmer, GC
    Cregan, EF
    Bialobok, P
    Sydserff, SG
    Hudzik, TJ
    McCarthy, DJ
    NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE, 1999, 890 : 406 - 420
  • [10] EVALUATION OF SOME PYRIDINE PHENETHYLAMINES AS ANTICONVULSANTS - IDENTIFICATION OF FPL-15896AR AS A SAFE, AND EFFICACIOUS NMDA ANTAGONIST WITH ANTICONVULSANT PROPERTIES
    BALESTRA, M
    MURRAY, RJ
    SCHMIESING, RJ
    BECKER, CW
    GRIFFITH, RC
    PALMER, GC
    STAGNITTO, ML
    FREEDMAN, L
    KAMP, D
    RAY, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 73 - MEDI
12345